• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE2
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Transient Ischemic Attack (2109); Obstruction/Occlusion (2422)
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.B.3 ¿ date of event: the date of the event was not reported.D.4: the product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Section e.1: initial reporter: the customer contact information, including name, occupation, phone, fax, and e-mail address, was not reported.H.4: the device manufacture date is not known as the device lot number is not available / not reported.The device remains implanted; therefore, no further investigation can be performed.The lot number is not known; therefore, a device history record review cannot be completed.Stent occlusion resulting in cerebral ischemia is a known potential complication associated with the enterprise2 stent and is mentioned in the instructions for use (ifu) as such.There were no alleged quality issues related to the used devices, as the devices performed as intended.The modified rankin scale (mrs) measures the degree of disability/dependence after a stroke.Since the patient¿s mrs score decreased by ¿more than 1,¿ this event does meet the criteria of a serious injury.Therefore, this event does meet us fda reporting criteria under 21 cfr 803 with a classification of ¿serious injury.¿ the file will be re-reviewed if additional information is received at a later date.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This is one of two products involved with the complaint and the associated manufacturer report numbers are 3008114965-2024-00431.
 
Event Description
It was reported, via a personal interaction, that two unknown enterprise2 stents (product code/lot # unknown) were used for a stent-assisted coil embolization of a ruptured saccular middle cerebral artery aneurysm.During the procedure, the user reported a stent-related ischemic complication developed and the patient¿s mrs decreased by more than 1.The event was reported as such, ¿the procedure was a stent-assisted coil embolization of a ruptured saccular middle cerebral artery aneurysm.2 stents of the enterprise 2 were implanted during the procedure.Stent occlusion and stent-related ischemic complication developed and mrs decreased by more than 1.Detailed information on the post-procedure patient¿s condition was unobtainable.Continuous flush was unknown.The lesion was middle cerebral artery.Other concomitant devices were unknown.¿ additional information was received on 23-apr-2024.Summary: per the information provided, regarding what the physician thinks may have caused or contributed to the event, it was commented, ¿stenosis and ischemic complication was related to stent implantation.¿ regarding if the event occurred intra-procedurally, if the thrombus was located within 5mm of the enterprise2 stent, the patient¿s baseline neurological status, how the event was treated, and if symptoms resolved, were all unobtainable information.No further information was made available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKENTERPRISE2
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key19190408
MDR Text Key341122631
Report Number3008114965-2024-00432
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE2
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/10/2024
Initial Date FDA Received04/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKENTERPRISE2
Patient Outcome(s) Life Threatening;
Patient Age45 YR
Patient SexMale
-
-